Functional dye-doped silica nanoparticles for bioimaging, diagnostics and therapeutics

Food and Bioproducts Processing

Volumn 83, Issue 2 C, 2005, Pages 136-140

  Santra, S ^a   Dutta, D ^a   Moudgil, B M ^a  

^a University of Florida   (United States)

Author keywords

Cancer; Dye doped nanoparticles; Fluorescence; Folate; TAT

Indexed keywords

CELLS; CHEMICAL MODIFICATION; DOPING (ADDITIVES); DYES; FLUORESCENCE; MEDICAL APPLICATIONS; MICROEMULSIONS; ONCOLOGY; SILICA; SURFACE TREATMENT; SYNTHESIS (CHEMICAL); VITAMINS;

BIOIMAGING; CANCER; DYE-DOPED SILICA NANOPARTICLES; FOLATE; THERAPEUTICS;

NANOSTRUCTURED MATERIALS;

EID: 22544440288     PISSN: 09603085     EISSN: None     Source Type: Journal    
DOI: 10.1205/fbp.04400     Document Type: Article

References (39)

1. Antony, A.C., 1992, The biological chemistry of folate receptors, Blood, 79(11): 2807-2820.
2. Astriab-Fisher, A., Sergueev, D.S., Fisher, M., Shaw, B.R. and Juliano, R.L., 2000, Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates, Biochem Pharmacol, 60 (1): 83-90.
3. Astriab-Fisher, A., Sergueev, D., Fisher, M., Shaw, B.R. and Juliano, R.L., 2002, Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions, Pharm Res, 19(6): 744-754.
4. Becker-Hapak, M., McAllister, S.S. and Dowdy, S.F., 2001, TAT-mediated protein transduction into mammalian cells, Methods, 24(3): 247-256.
5. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G. and Prochiantz, A., 1996, Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent, J Biol Chem, 271(30): 18188-18193.
6. Elliott, G. and Ohare, P., 1997, Intercellular trafficking and protein delivery by a herpesvirus structural protein, Cell, 88(2): 223-233.
7. Evans, C.-O., Reddy, P., Brat, D.J., O'Neill, E.B., Craige, B., Stevens, V.L. and Oyesiku, N.M., 2003, Differential expression of folate receptor in pituitary adenomas, Cancer Res, 63(14): 4218-4224.
8. Frankel, A.D. and Pabo, C.O., 1988, Cellular uptake of the Tat protein from human immunodeficiency virus, Cell, 55(6): 1189-1193.
9. Franklin, W.A., Waintrub, M., Edwards, D., Christensen, K., Prendegrast, P., Woods, J., Bunn, Pa. and Kolhouse, J.F., 1994, New anti-lung-cancer antibody cluster-12 reacts with human folate receptors present on adenocarcinoma, Int J Cancer, Suppl 8: 89-95.
10. Green, M. and Loewenstein, P.M., 1988, Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein, Cell, 55(6): 1179-1188.
11. Hayflick, L., 2000, The illusion of cell immortality, Brit J Cancer, 83(7): 841-846.
12. Holm, B.A., Bergey, E.J., De, T., Rodman, D.J., Kapoor, R., Levy, L., Friend, C.S. and Prasad, P.N., 2002, Nanotechnology in biomedical applications, Molecular Crystals and Liquid Crystals, 374: 589-598.
13. Jarver, P. and Langel, U., 2004, The use of cell-penetrating peptides as a tool for gene regulation, Drug Discovery Today, 9(9): 395-402.
14. Kranz, D.M., Manning, T.C., Rund, L.A., Cho, B.K., Gruber, M.M. and Roy, E.J., 1998, Targeting tumor cells with bispecific antibodies and T cells, J Control Release, 53(1-3): 77-84.
15. Leamon, C.P. and Low, P.S., 1991, Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis, Proc Natl Acad Sci USA, 88(13): 5572-5576.
16. Leamon, C.P. and Low, P.S., 2001, Folate-mediated targeting: from diagnostics to drug and gene delivery, Drug Discovery Today, 6 (1): 44-51.
17. Levchenko, T.S., Rammohan, R., Volodina, N. and Torchilin, V.P., 2003, Tat peptide-mediated intracellular delivery of liposomes, Liposomes, Pt B, 372: 339-349.
18. Lewin, M., Carlesso, N., Tung, C. H., Tang, X.W., Cory, D, Scadden, D.T. and Weissleder R., 2000, Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, Nature Biotechnol, 18(4): 410-414.
19. Michalet, X., Pinaud, F.F., Bentolila, L.A., Tsay, J.M., Doose, S., Li, J.J., Sundaresan, G., Wu, A.M., Gambhir, S.S. and Weiss, S., 2005, Quantum dots for live cells, in vivo imaging, and diagnostics, Science, 307(5709): 538-544.
20. Phelan, A., Elliott, G., and O'Hare, P., 1998, Intercellular delivery of functional p53 by the herpesvirus protein VP22, Nature Biotechnol, 16(5): 440-443.
21. Polyakov, V., Sharma, V., Dahlheimer, J.L., Pica, C.M., Luker, G.D. and Piwnica-Worms, D., 2000, Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy, Bioconjugate Chem, 11(6): 762-771.
22. Qhobosheane, M., Santra, S., Zhang, P. and Tan, W.H., 2001, Biochemically functionalized silica nanoparticles, Analyst, 126 (8): 1274-1278.
23. Ross, J.F., Chaudhuri, P.K. and Ratnam, M., 1994, Differential regulation of folate receptor isoforms in normal and malignant-tissues in-vivo and in established cell-lines - physiological and clinical implications, Cancer, 73(9): 2432-2443.
24. Rund, L.A., Cho, B.K., Manning, T.C., Holler, P.D., Roy, E.J. and Kranz, D.M., 1999, Bispecific agents target endogenous murine T cells against human tumor xenografts, Int J Cancer, 83(1): 141-149.
25. Santra, S., Wang, K.M., Tapec, R. and Tan, W.H., 2001a, Development of novel dye-doped silica nanoparticles for biomarker application, J Biomed Opt, 6(2): 160-166.
26. Santra, S., Zhang, P., Wang, K.M., Tapec, R. and Tan, W.H., 2001b, Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers, Anal Chem, 73(20): 4988-4993.
27. Santra S., Xu, J.S., Wang, K.M. and Tan, W.H., 2004a, Luminescent nanoparticle probes for bioimaging, J Nanosci and Nanotechnol, 4(6): 590-599.
28. Santra, S., Yang, H., Dutta, D., Stanley, J.T., Holloway, P.H., Tan, W.H., Moudgil, B.M. and Mericle, R.A., 2004b, TAT conjugated, FITC doped silica nanoparticles for bioimaging applications, Chem Commun, 24: 2810-2811.
29. Schwarze, S.R., Ho, A., Vocero-Akbani, A. and Dowdy, S.F., 1999, In vivo protein transduction: delivery of a biologically active protein into the mouse, Science, 285(5433): 1569-1572.
30. Sokolov, K., Aaron, J., Hsu, B., Nida, D., Gillenwater, A., Follen, M., MacAulay, C., Adler-Storthz, K., Korgel, B., Descour, M., Pasqualini, R., Arap, W., Lam, W. and Richards-Kortum R., 2003, Optical systems for in vivo molecular imaging of cancer, Technol Cancer Res Treat, 2(6): 491-504.
31. Soomets, U., Lindgren, M., Gallet, X., Hallbrink, M., Elmquist, A., Balaspiri, L., Zorko, M., Pooga, M., Brasseur, R. and Langel, U., 2000, Deletion analogues of transportan, BBA-Biomembranes, 1467 (1): 165-176.
32. Stein, S., Weiss, A., Adermann, K., Lazarovici, P., Hochman, J. and Wellhoner, H., 1999, A disulfide conjugate between anti-tetanus antibodies and HIV (37-72)Tat neutralizes tetanus toxin inside chromaffin cells, Febs Letters, 458(3): 383-386.
33. Sudimack, J. and Lee, R.J., 2000, Targeted drug delivery via the folate receptor, Adv Drug Deliv Rev, 41(2): 147-162.
34. Tan, W.H., Wang, K.M., He, X.X., Zhao, X.J., Drake, T., Wang, L. and Bagwe, R.P., 2004, Bionanotechnology based on silica nanoparticles, Med Res Rev, 24(5): 621-638.
35. Tapec, R., Zhao, X.J.J. and Tan, W.H., 2002, Development of organic dye-doped silica nanoparticles for bioanalysis and biosensors, J Nanosci Nanotechnol, 2(3-4): 405-409.
36. Taylor, C.T., Furuta, G.T., Synnestvedt, K. and Colgan, S.P., 2000, Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia, Proc Nat Acad Sci USA, 97(22): 12091-12096.
37. Torchilin, V.P. and Levchenko, T.S., 2003, TAT-liposomes: a novel intracellular drug carrier, Curr Protein Pepti Sci, 4(2): 133-140.
38. Zhao, M., Kircher, M.F., Josephson, L. and Weissleder, R., 2002, Differential conjugation of TAT peptide to superparamagnetic nanoparticles and its effect on cellular uptake, Bioconjugate Chem, 13(4): 840-844.
39. Zhao, M. and Weissleder, R., 2004, Intracellular cargo delivery using tat peptide and derivatives, Med Res Rev, 24(1): 1-12.